Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7468 p249
8 September 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Not providing advanced services will harm pharmacy's reputation

About half the pharmacies in England are still not providing advanced services, Sue Sharpe, chief executive of the Pharmaceutical Services Negotiating Committee, revealed this week at the UniChem convention in Barbados.

“If we want to be in the frame”, said Mrs Sharpe, “we need to work to be there.” She said that the number of contractors who have not changed their practice or premises is worrying. “They are a real problem for the reputation of pharmacy, for everyone.”

“Other providers, including the voluntary sector, are being encouraged to tender for providing services,” she pointed out. “And in case anyone thinks that, longer term, a simple dispensing service will provide a profitable business, think again — it will not,” Mrs Sharpe warned participants.

She went on: “The contractual framework [in England and Wales] offers a window of security, giving pharmacists time and the financial comfort to shift from a dispensing service to providing a wider range of health care. Too many pharmacists have not made that shift.” She believes that many are doing the minimum to meet the contract requirements.

“We will find it impossible to protect nationally negotiated services if large numbers of contractors turn their backs on them,” she added.

Mike Smith, UniChem convention chairman, said he was “horrified by the lack of engagement of some pharmacists with the new contract. They do no medicines use reviews, they have shoddy premises, they have cupboards for consulting rooms, their hours don’t fit with the local surgery — and we all know of them.”

He pointed out that the profession is often judged by the worst that represent it. “Get your act together now,” he stressed.

“We hear all kinds of reasons why pharmacists don’t do [MURs] — lack of time, lack of training and — dare I say it — lack of confidence,” he added.

Back to Top


©The Pharmaceutical Journal